Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
10.01
+0.25 (2.56%)
At close: Dec 20, 2024, 4:00 PM
10.03
+0.02 (0.20%)
After-hours: Dec 20, 2024, 5:17 PM EST
Zenas BioPharma Revenue
In the year 2023, Zenas BioPharma had annual revenue of $50.00M.
Revenue (ttm)
$50.00M
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
$438,596
Employees
114
Market Cap
418.33M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 50.00M | - | - |
| Dec 31, 2022 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionZBIO News
- 5 weeks ago - Zenas BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 5 weeks ago - Zenas BioPharma Completes Targeted Enrollment of the Phase 3 INDIGO Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD) - GlobeNewsWire
- 6 weeks ago - Zenas BioPharma to Participate in Upcoming Healthcare Investor Conferences - GlobeNewsWire
- 3 months ago - Zenas BioPharma Announces Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares in Initial Public Offering - GlobeNewsWire
- 3 months ago - U.S. IPO Weekly Recap: 3 Biotechs Lead Active September IPO Market - Seeking Alpha
- 3 months ago - Zenas BioPharma Announces Pricing of Upsized Initial Public Offering - GlobeNewsWire
- 3 months ago - U.S. IPO Weekly Recap: 2 APAC Microcaps Go Public In Short Labor Day Week As The Pipeline Grows - Seeking Alpha
- 4 months ago - Zenas BioPharma Seeks IPO For Inflammatory Treatment Trials - Seeking Alpha